Effectiveness of a Natural Ingredient on Appetite Regulation
NCT ID: NCT04345029
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2020-01-15
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Natural Ingredient on Obesity
NCT04105192
To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects
NCT04506749
Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals
NCT05758363
Chronic Study on Body Composition, Training, Performance, and Recovery
NCT04230824
Safety Analysis of Chronic Intake of a β-alanine Supplement
NCT05334121
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group (Lippia citriodora + sabdariffa)
Consumption for 60 days of Lippia citriodora 325 mg + Hibiscus sabdariffa 175 mg.
Two capsules per day will be consumed thirty minutes before breakfast orally for 60 days.
Dietary supplement consumption
The experimental product consumption time was 60 days and the control consumption time was 60 days.
Each subject must consume both products, with a washing period of 30 days.
control group Placebo (sucrose)
Two capsules per day will be consumed thirty minutes before breakfast orally for 60 days.
Dietary supplement consumption
The experimental product consumption time was 60 days and the control consumption time was 60 days.
Each subject must consume both products, with a washing period of 30 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary supplement consumption
The experimental product consumption time was 60 days and the control consumption time was 60 days.
Each subject must consume both products, with a washing period of 30 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genders.
* BMI 25-34.9 kg / m2, both inclusive.
* Weight maintained during the last 3 months.
* Smoking subjects or not, but in any case they do not change their nicotinic habits during their participation in the study.
* Absence of disease diagnosed at the start of the study.
Exclusion Criteria
* History of allergic hypersensitivity or poor tolerance to any component of the products under study.
* Subjects who are performing or intend to carry out any type of diet, low-calorie or not, during the study.
* Participation in another clinical trial in the three months prior to the study.
* Lack of will or inability to comply with clinical trial procedures.
* Pregnant woman.
* Subjects whose condition does not make them eligible for the study according to the researcher's criteria.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Javier López Román
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic University of Murcia
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCAMCFE-00012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.